IDEAYA Biosciences to Participate in Upcoming May 2024 Investor Relations Event

Rhea-AI Summary

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) will participate in the RBC Capital Markets Global Healthcare Conference on May 14th, 2024. The event will feature a fireside chat with CEO Yujiro S. Hata. The company aims to engage with investors and showcase its precision medicine oncology initiatives.

News Market Reaction – IDYA

+1.30%

+1.30% Session move

In the trading session that priced this news, IDYA gained 1.30%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SOUTH SAN FRANCISCO, Calif., May 1, 2024 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation in an upcoming investor relations event.

RBC Capital Markets Global Healthcare Conference
Tuesday, May 14^th, 2024 at 3:05 PM ET

• Fireside chat with Yujiro S. Hata, Chief Executive Officer, hosted by Gregory Renza, Director and Senior Biotechnology Research Analyst

A live audio webcast of the conference event, as permitted by the conference host, will be available at the "Investors/Events" section of the IDEAYA website at https://ir.ideayabio.com/events and/or through the conference host.  A replay of available webcasts will be accessible for 30 days following the live event.

About IDEAYA Biosciences

IDEAYA is a precision medicine oncology company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics.  IDEAYA's approach integrates capabilities in identifying and validating translational biomarkers with drug discovery to select patient populations most likely to benefit from its targeted therapies.  IDEAYA is applying its early research and drug discovery capabilities to synthetic lethality – which represents an emerging class of precision medicine targets. 

Forward-Looking Statements

This press release contains forward-looking statements, including, but not limited to, statements related to participation in and/or presentation at certain investor relations events. IDEAYA undertakes no obligation to update or revise any forward-looking statements. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of IDEAYA in general, see IDEAYA's recent Annual Report on Form 10-K filed on February 20, 2024 and any current and periodic reports filed with the U.S. Securities and Exchange Commission.

Investor and Media Contact
IDEAYA Biosciences
Andres Ruiz Briseno
Senior Vice President, Head of Finance and Investor Relations
investor@ideayabio.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/ideaya-biosciences-to-participate-in-upcoming-may-2024-investor-relations-event-302130345.html

SOURCE IDEAYA Biosciences, Inc.

FAQ

When will IDEAYA Biosciences participate in the RBC Capital Markets Global Healthcare Conference?

IDEAYA Biosciences will participate in the RBC Capital Markets Global Healthcare Conference on May 14th, 2024.

Who will be featured in the fireside chat during the event?

The fireside chat will feature CEO Yujiro S. Hata.

Where can investors access the live audio webcast of the conference event?

Investors can access the live audio webcast at the 'Investors/Events' section of the IDEAYA website at https://ir.ideayabio.com/events.

How long will the replay of the webcasts be accessible for?

The replay of available webcasts will be accessible for 30 days following the live event.